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Abstract: Hemotropic mycoplasmas (hemoplasmas) have been reported in several mammalian species. In
dogs, two species have been described: Mycoplasma haemocanis and ‚Candidatus Mycoplasma haematoparvum’.
Infections can lead to hemolytic anemia, but the clinical importance of the two canine hemoplasma species
needs to be further investigated. No data on the presence of canine hemoplasmas in Switzerland has been
published, but the tick Rhipicephalus sanguineus, a proposed vector for canine hemoplasmas, is occasion-
ally encountered in the canton Ticino. The aim of the present study was to investigate the importance
of M. haemocanis and ‘Candidatus M. haematoparvum’ in the Swiss dog population. Blood samples
from 889 dogs were analyzed with two sensitive real-time PCR assays. For phylogenetic analyses, the
16S rRNA genes of four isolates were sequenced. Overall, hemoplasma infections were rarely detected
in Swiss dogs: M. haemocanis was found in eight (0.9%) and ‘Candidatus M. haematoparvum’ in three
(0.3%) tested dogs. The sequenced isolates revealed ￿ 99.8% identity to published sequences. Only two
infected dogs showed mild anemia. In one ‘Candidatus M. haematoparvum’ and two M. haemocanis
infected animals a chronic carrier status of three to 13 months was demonstrated. Interestingly, the
majority of the infected dogs had paid visit to regions where R. sanguineus is frequently found. Accord-
ing to our results, canine hemoplasma infections play only a subordinate role in dogs in Switzerland.
Haemotrope Mykoplasmen (Haemoplasmen) wurden bei diversen Säugetieren beschrieben. Beim Hund
sind Mycoplasma haemocanis und ‚Candidatus Mycoplasma haematoparvum’ bekannt. Infektionen kön-
nen zu einer hämolytischen Anämie führen; die klinische Bedeutung der beiden Erreger bedarf jedoch
weiterer Untersuchungen. Es existieren bislang keine Daten über das Vorkommen von caninen Haemo-
plasmen in der Schweiz. Die Zecke Rhipicephalus sanguineus, die als Vektor in Frage kommt, kann
gelegentlich im Kanton Tessin gefunden werden. Das Ziel der vorliegenden Studie war es, die Bedeutung
von M. haemocanis und ‘Candidatus M. haematoparvum’ in der Schweizer Hundepopulation zu unter-
suchen. Blutproben von 889 Hunden wurden mittels zwei sensitiver real-time PCR Methoden analysiert.
Von vier Isolaten wurde für phylogenetische Analysen das 16S rRNA Gen sequenziert. Insgesamt wurden
Haemoplasmen- Infektionen nur bei wenigen Hunden detektiert: M. haemocanis wurde in acht (0.9%) und
‘Candidatus M. haematoparvum’ in drei (0.3%) der getesteten Tiere gefunden. Die sequenzierten Isolate
zeigten ￿ 99.8% Übereinstimmung mit publizierten Sequenzen. Nur zwei der infizierten Hunde zeigten eine
leichtgradige Anämie. Bei einem ‘Candidatus M. haematoparvum’- und zwei M. haemocanis-infizierten
Tieren konnte ein chronisches Trägerstadium über einen Zeitraum von bis zu 13 Monaten gezeigt werden.
Interessanterweise hatte die Mehrheit der infizierten Hunde Regionen bereist, in denen R. sanguineus
häufig vorkommt. Gemäss unseren Resultaten spielen canine Haemoplasmen-Infektionen bei Hunden in
der Schweiz nur eine untergeordnete Rolle.
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1 Summary 
Hemotropic mycoplasmas (hemoplasmas) have been reported in several 
mammalian species. In dogs, two species have been described: Mycoplasma 
haemocanis and ‚Candidatus Mycoplasma haematoparvum’. Infections can 
lead to hemolytic anemia, but the clinical importance of the two canine 
hemoplasma species needs to be further investigated. No data on the 
presence of canine hemoplasmas in Switzerland has been published, but the 
tick Rhipicephalus sanguineus, a proposed vector for canine hemoplasmas, is 
occasionally encountered in the canton Ticino. The aim of the present study 
was to investigate the importance of M. haemocanis and ‘Candidatus 
M. haematoparvum’ in the Swiss dog population. Blood samples from 
889 dogs were analyzed with two sensitive real-time PCR assays. For 
phylogenetic analyses, the 16S rRNA genes of four isolates were sequenced. 
Overall, hemoplasma infections were rarely detected in Swiss dogs: 
M. haemocanis was found in eight (0.9%) and ‘Candidatus 
M. haematoparvum’ in three (0.3%) tested dogs. The sequenced isolates 
revealed ≥ 99.8% identity to published sequences. Only two infected dogs 
showed mild anemia. In one ‘Candidatus M. haematoparvum’ and two 
M. haemocanis infected animals a chronic carrier status of three to 13 months 
was demonstrated. Interestingly, the majority of the infected dogs had paid 
visit to regions where R. sanguineus is frequently found. According to our 
results, canine hemoplasma infections play only a subordinate role in dogs in 
Switzerland. 
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2 Introduction 
The presence of epierythrocytic bacteria in blood smears from dogs with 
anemia have been reported worldwide (2, 3, 11, 14, 23, 24, 33). The 
respective agent, Haemobartonella canis, has recently been reclassified within 
the group of hemotropic mycoplasmas (hemoplasmas) as Mycoplasma 
haemocanis (21). Phylogenetic studies based on the 16S rRNA and Rnase P 
genes revealed a close relationship of M. haemocanis to the feline pathogen 
Mycoplasma haemofelis (5, 21). Recently, a second canine hemoplasma was 
discovered in the United States of America (USA) in a splenectomized dog 
with hemic neoplasia and designated ‘Candidatus Mycoplasma 
haematoparvum’ (27). The latter agent shows a close phylogenic relationship 
to the feline hemoplasma ‘Candidatus Mycoplasma haemominutum’ (28). 
Clinical cases of hemoplasmosis in dogs have occasionally been reported (2, 
3, 7, 11, 14, 19, 23, 33). Co-factors such as splenectomy (3, 7, 14, 19, 33), 
immunosuppression (2) or concurrent infections (11, 33) seem to play a role in 
the pathogenesis of canine hemoplasmosis. A chronic carrier status may be 
present in healthy dogs (3, 12). Of note, most of the so far published studies 
relied upon cytological identification of the organisms on blood smears (2, 3, 
11, 19, 23, 24, 33), a method with a low diagnostic sensitivity and specificity 
(15). The recent development of PCR-based assays to diagnose canine 
hemoplasmas allows a more sensitive detection of these agents and the 
differentiation of the two described species (16). So far, only one study used 
real-time PCR-based methods to investigate the prevalence of canine 
hemoplasmosis in a sample of 460 dogs from Southern France (16): overall, 
15.4% of the dogs tested PCR positive for canine hemoplasmas. Noteworthy, 
R. sanguineus, a proposed vector for canine hemoplasmas (26) is commonly 
encountered in Southern France (10). Recently, higher infection rates have 
been reported in kennel-raised dogs from Western Europe, Eastern Europe 
and North America (15). It was hypothesized that the possibility of a 
 3 
transplacental transmission (18) would perpetuate an infection, once 
established, in kennel-raised dogs (15). However, the transmission routes of 
canine hemoplasmas are still unknown. 
This study aimed I) to investigate for the first time the presence of 
hemoplasma infections in dogs in Switzerland using sensitive real-time PCR 
assays, II) to follow hemoplasma-infected dogs over time and III) to 
molecularly characterize the hemoplasma isolates. 
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3 Materials and Methods 
3.1 Sample collection 
EDTA-anticoagulated blood samples from 889 Swiss dogs were collected 
throughout a one year period starting from December 2005. All but one dog 
were presented for various reasons at the Clinic for Small Animals, Vetsuisse 
Faculty, University of Zurich, Switzerland: they included 882 sick dogs from 
which blood samples had been taken for diagnostic purposes and six healthy 
blood donors. The blood sample from one sick dog was sent in by a practicing 
veterinarian for diagnostic purposes. In addition, seven follow-up blood 
samples from three hemoplasma PCR-positive dogs were available. 
 
3.2 Hematological analysis 
Packed cell volume (PCV) values determined on a Cell-Dyn 3500 (Abbott, 
Baar, Switzerland) were available from 875 dogs. PCV values between 42% 
and 55% (5% and 95% quantiles, reference range of the Clinical Laboratory, 
Zurich, Switzerland) were considered to be within the normal range; anemia 
was defined as a PCV value below 42%. 
 
3.3 Medical records 
Information about gender and age of all dogs included in this study were 
obtained from the Clinic for Small Animals of the University of Zurich, 
Switzerland. Complete medical records were only recorded for hemoplasma 
PCR-positive dogs. The latter data included breed, place of domicile, clinical 
diagnosis, treatment and travel history (to foreign countries or Southern 
Switzerland, canton Ticino). The presence of an intact spleen was confirmed 
by data from X-ray or ultrasonographic investigations. 
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3.4 TNA extraction 
Total nucleic acids (TNA) were extracted from 200 µl (155 initial and one 
follow-up sample) or from 100 µl (734 initial and six follow-up samples) EDTA-
anticoagulated blood using the MagNaPure LC Total Nucleic Acid Isolation Kit 
(Roche Diagnostics, Rotkreuz, Switzerland). Negative controls consisting of 
200 µl phosphate buffered saline were prepared with each batch of 
15 samples. Extracted samples were stored at -80°C until use. 
 
3.5 Quantitative real-time PCR assays and standards 
All samples were analyzed by real-time PCR for the presence of canine 
hemoplasmas. For the detection of M. haemocanis a published M. haemofelis 
real-time PCR assay was used; due to high sequence homology, the latter 
assay amplifies both hemoplasmas (30). A modified ‚Candidatus 
M. haemominutum’ real-time PCR assay (30) was used for the detection of 
‚Candidatus M. haematoparvum’ with the forward primer adapted as follows: 
5’-GAA AGT CTG ATG GAG CAA TAC CAC-3’. To evaluate the sensitivity of 
the latter assay, 77 samples were additionally analyzed with a published real-
time PCR assay for ‚Candidatus M. haematoparvum’ (16). 
All real-time PCR assays were performed using an ABI PRISM 7700 
Sequence Detection System (Applied Biosystems, Rotkreuz, Switzerland). In 
each run, the amplification buffer contained dUTP for the use with uracil-N-
glycosylase to prevent carryover of PCR amplicons and water was used as a 
negative control. 
For absolute quantification, plasmids containing the cloned 16S rRNA gene of 
‘Candidatus M. haematoparvum’ were generated (see below). Purified DNA 
was linearized by restriction digestion with NotI (Promega, Catalys AG, 
Wallisellen, Switzerland) and the copy number was calculated by both 
spectrophotometer (GeneQuantTM, Amersham-Parmacia Biotech, Otelfingen, 
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Switzerland) and agarose gel electrophoresis (Syngene, Gene Tools software, 
Syngene, Cambridge, United Kingdom). The ‚Candidatus M. haematoparvum’ 
DNA was serially tenfold diluted in a solution of 30 µg/ml of salmon sperm 
DNA (Invitrogen, Basel, Switzerland) (31). For M. haemocanis quantification, a 
published standard based on the 16S rRNA gene of M. haemofelis was used 
(30). 
 
3.6 Sequencing of 16S rRNA genes 
The near complete 16S rRNA gene from three M. haemocanis isolates 
(dog 201, 1725 and 1769; Table 1) and one ‘Candidatus M. haematoparvum’ 
isolate (dog 252; Table 2) was sequenced. For both agents, primers were 
designed (M. haemocanis forward primer 5’-TCG AAC GGA CCT TGG TTT 
CG-3’ and reverse primer 5’-CAA ATA AAT GTA TTT TTA AAT GCC CAC-3’, 
‘Candidatus M. haematoparvum’ forward primer 5’-GCT CAG GAT TAA TGC 
TGG TGG-3’ and reverse primer 5’-GGG CGG TGT GTA CAA GAC CT-3’) 
that amplify a 1330 bp and 1354 bp fragment of the gene, respectively. The 
reaction mixture contained 5 µl of 5 X HF PCR buffer (Finnzymes, BioConcept, 
Allschwil, Switzerland), 800 nM each primer, 200 nM of each deoxynucleoside 
triphosphate (Sigma-Aldrich, Buchs, Switzerland), 1 U Phusion High-Fidelity 
DNA Polymerase (Finnzymes) and 5 µl template TNA made up to 25 µl with 
water. The program comprised 98°C for 3 min, 35 cycles of 98°C for 10 s, 
60.8°C (M. haemocanis) or 63.2°C (‘Candidatus M. haematoparvum’) for 30 s, 
72°C for 1 min, and a final elongation at 72°C for 10 min. A-tailing was 
performed in a reaction mixture comprising 8 µl of the PCR product, 1.2 µl of 
10 X PCR buffer, 200 nM dATP and 1 U of Taq DNA Polymerase (all reagents 
from Sigma-Aldrich) filled up with water to a final volume of 12 µl. The reaction 
was performed at 72°C for 15 min. The TOPO TA Cloning Kit for Sequencing 
containing the pCR 4–TOPO vector (Invitrogen) was used for cloning and 
plasmid DNA was purified using the QIAprep Spin Miniprep Kit (Qiagen, 
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Hombrechtikon, Switzerland). Sequencing was performed with M13 forward 
and reverse primers and an internal primer (5’-AGC AAT ACC ATG TGA ACG 
ATG AA-3’) using the BigDye Terminator v1.1 Cycle Sequencing Kit (Applied 
Biosystems) under standard cycling conditions. Products were purified with 
SigmaSpin Post-Reaction Clean-Up Columns (Sigma-Aldrich) and analyzed 
on an ABI PRISM 310 Genetic Analyzer (Applied Biosystems). For sequence 
comparison, the GCG Wisconsin Package (Accelrys GmbH, Munich, 
Germany) was used. A phylogenetic tree was constructed with the neighbor-
joining method from a distance matrix corrected for nucleotide substitutions by 
the Kimura two-parameter model (17). 
 
3.7 Statistics 
Categorical variables (gender, presence of anemia and infection) were 
compared between groups using the Chi2 Test (6). Age was compared 
between PCR-positive and  -negative dogs using the Mann-Whitney U Test 
(6). 
 
3.8 Nucleotide sequence accession numbers 
The partial 16S rRNA gene nucleotide sequences have been submitted to 
GenBank (M. haemocanis: EF416566 - EF416568; ‘Candidatus 
M. haematoparvum’: EF416569). 
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4 Results 
4.1 Real-time PCR assays 
All extraction and PCR controls tested PCR negative. The ‘Candidatus 
M. haematoparvum’ assay was able to detect 1 copy/reaction of ‘Candidatus 
M. haematoparvum’ DNA (10/10 reactions positive). All 77 samples that were 
tested in parallel with two different real-time PCR assays for ‘Candidatus 
M. haematoparvum’ revealed identical results (one out of 77 samples positive). 
 
4.2 Sample prevalence of canine hemoplasmas in the Swiss dog 
population 
M. haemocanis DNA was detected in eight (0.9%) and ‘Candidatus 
M. haematoparvum’ DNA in three (0.3%) out of 889 Swiss dogs. No dog was 
found to be dually infected with both canine hemoplasmas. The samples from 
the six healthy blood donors included in the study were found to be PCR 
negative. 
 
4.3 Hematology analysis 
Out of the 864 PCR-negative dogs with hematological data, 295 (34.1%; 143 
female and 152 male dogs) were considered anemic, 547 (63.3%; 277 female 
and 270 male dogs) had PCV values within the reference range, and 22 dogs 
(2.5%; 14 female and 8 male dogs) had values above the reference range. In 
the eleven hemoplasma-infected dogs, the PCV values of nine animals initially 
were within the reference range (81.8%); one infected dog showed a slight 
anemia (PCV 40%). One infected greyhound had a PCV value of 62%. The 
latter value can be judged as normal, because this breed is known to show 
physiologically elevated PCV values. No significant association between the 
occurrence of canine hemoplasma infection and anemia was found. 
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4.4 Hemoplasma blood loads 
All samples from the eleven PCR-positive dogs underwent quantitative real-
time PCR assays for the assessment of hemoplasma loads. Seven 
M. haemocanis PCR-positive dogs had loads ranging from 33 to 5.2 x 
105 DNA copies per ml blood. One of these M. haemocanis PCR-positive dogs 
tested positive in only one out of six PCR samples (33 DNA copies per ml 
blood). The ‘Candidatus M. haematoparvum’ blood loads of two PCR-positive 
dogs were 5.8 x 102 and 2.1 x 103 DNA copies per ml blood, respectively. The 
load of one M. haemocanis and one ‘Candidatus M. haematoparvum’ PCR-
positive dog could not be quantified because the samples repeatedly tested 
real-time PCR negative when rerun for absolute quantification. Thus, the loads 
in these animals were assumed to be < 33 DNA copies per ml blood. 
 
4.5 Characteristics of hemoplasma PCR-positive dogs 
Five hemoplasma infected dogs were of male gender, six were females 
(gender of the PCR-negative dogs: 437 males, 441 females); no significant 
association between gender and presence of a canine hemoplasma infection 
was found. The age of the infected dogs ranged from three to 13 years 
(median age: 8 years; 5% quantile: 4 years, 95% quantile: 12.5 years); for the 
PCR-negative dogs the age ranged from below one to 18 years (median age: 
8 years; 5% quantile: 1 year, 95% quantile: 14 years). No significant difference 
in age was found between the PCR-negative and  -positive dogs. Eight 
hemoplasma-infected dogs were pure bred; three animals were crossbred 
(Tables 1 and 2).  
Ten hemoplasma-infected dogs had their place of domicile north of the Alps, 
one lived in Southern Switzerland (canton Ticino). At least two hemoplasma-
infected dogs sojourned in Southern Switzerland (Table 1). Ten out of eleven 
infected dogs (90.9%) have not spent their entire life in Switzerland. Travel 
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histories are listed in Tables 1 and 2. Three dogs were imported from Italy and 
two dogs were adopted from Mexico and Spain, respectively. Travel history 
was incomplete in dog 954 (Table 1). 
The hemoplasma infected dogs were presented at the clinics for diverse 
reasons. Four infected dogs were diagnosed with tumors (Tables 1 and 2). 
Two dogs showed lacerations due to fighting and one animal had a degloving 
limb injury (hit by car). Gastrointestinal, cardiac and muscular diseases were 
diagnosed in four animals (Tables 1 and 2). Eight of the PCR-positive dogs 
have not undergone splenectomy. No data from radiology or ultrasonography 
was available from the remaining three infected dogs. Two infected dogs were 
iatrogenic immunosuppressed by prednisolone and lomustine, respectively 
(see below). 
 
4.6 Follow-up of hemoplasma-infected dogs 
For three hemoplasma PCR-positive dogs, a total of seven follow-up data 
samples were available; all seven samples yielded PCR-positive results 
(Fig. 1). The ‘Candidatus M. haematoparvum’ infected dog 252 remained PCR 
positive for a 400 day follow-up period (Fig. 1A). This dog underwent cytostatic 
chemotherapy with lomustine (60-70 mg/m2 body surface area every three 
week). The dog received four applications, the last one at the time of the first 
blood sample collection for the present study (Fig. 1A). 
Two M. haemocanis PCR-positive dogs remained positive for a period of 
100 days and 270 days (Fig. 1B and C). The M. haemocanis infected 
dog 1725 (Fig. 1B) was presented nine months after initial presentation in a 
very poor general condition (suspicion diagnosis: metastasizing cancer) and 
was euthanized. The PCV value of this dog had decreased from 42% at the 
first visit to 34% at this second appointment. The second M. haemocanis 
infected dog with follow-up data (dog 201, Fig. 1C) was treated with an 
immunosuppressive dosage of prednisolone up to the day of the second blood 
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investigation by PCR, the medication was thenceforward reduced to an anti-
inflammatory dosage (Fig. 1C). Only moderate fluctuations of the blood loads 
were seen in the M. haemocanis and the ‚Candidatus M. haematoparvum’ 
follow-up samples with a maximal decrease by a factor of 40 within one week 
in the M. haemocanis infected dog 201 (Fig. 1C). 
 
4.7 Sequencing of 16S rRNA genes 
To confirm the PCR results and to evaluate sequence variations, the 16S 
rRNA genes of four canine hemoplasma isolates were almost completely 
sequenced. The data revealed 99.9% to 100% identity of the three 
M. haemocanis isolates with a published M. haemocanis sequence 
(AF407208) and 99.8% identity of the ‚Candidatus M. haematoparvum’ isolate 
with a published sequence of ‚Candidatus M. haematoparvum’ (AY383241). 
Phylogenetic analyses revealed that the Swiss ‚Candidatus 
M. haematoparvum’ isolate clustered together with an isolate from the USA 
(Fig. 2). All three M. haemocanis isolates from Switzerland were localized 
within the same subcluster as were all M. haemocanis isolates included in the 
phylogenetic tree (Fig. 2). 
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5 Discussion 
This is the first study to investigate the occurrence of canine hemoplasma 
infections in dogs in Switzerland. In addition, we document for the first time 
PCR-based follow-ups for the two canine hemoplasma species. 
Hemotropic mycoplasma infections were rarely detected in Swiss pet dogs 
(1.2%), suggesting that these agents play only a marginal role in dogs in 
Switzerland. Recently, a real-time PCR-based study in 460 dogs from 
Southern France detected 15 (3.3%) M. haemocanis and 44 (9.6%) 
‘Candidatus M. haematoparvum’ singly infected dogs and 12 (2.6%) dogs co-
infected with both hemoplasmas (16). A study based on conventional PCR in 
free-roaming dogs in Sudan found even higher hemoplasma infection rates 
(13). Interestingly, more than half of the latter dogs were found infested with 
the tick R. sanguineus, a proposed vector for canine hemoplasmas (26). In 
contrast to Southern France and Sudan, R. sanguineus is not indigenous to 
Switzerland; it is only occasionally encountered in the southern part of the 
country (canton Ticino) (4) whereas in Northern Switzerland, the climate is too 
cold for Rhipicephalus ticks to permanently establish. Most ticks in Switzerland 
belong to the genus Ixodes, but no feline and canine hemoplasma DNA was 
recently detected by real-time PCR in almost 2,000 Ixodes ticks collected from 
vegetation in Northern Switzerland (32). Thus, we hypothesize that the low 
prevalence of canine hemoplasma infections in Switzerland may be due to the 
lack of appropriate arthropod vectors and that canine hemoplasmosis plays 
predominantly a role in countries where dogs are commonly exposed to 
Rhipicephalus ticks. This is further supported by the finding that the majority of 
the infected dogs in the present study had visited countries where 
R. sanguineus is permanently established, such as Italy, Spain, France, 
Serbia, the USA and Mexico (1, 8-10, 22, 25); these dogs could have acquired 
the hemoplasma infection abroad. Three infected dogs in the present study 
spent time or lived in the canton Ticino, where R. sanguineus is occasionally 
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encountered. A recent study failed to detect canine hemoplasmas in 
Rhipicephalus ticks collected from pet animals in the canton Ticino (32). 
However, this could be due to the low sample size under investigation 
(23 R. sanguineus, 44 Rhipicephalus sp.). Future studies should therefore be 
conducted to investigate different arthropod vectors and other potential ways 
of transmission in more depth to address their role in the epizoology of canine 
hemoplasma infections. 
Recently, hemotropic mycoplasma infection in cats was found to be associated 
with male gender, old age and sometimes anemia (29, 30). In contrast, but in 
accordance with the real-time PCR based investigations in French dogs (16), 
we found no association of canine hemotropic mycoplasma infection with 
gender and age in the dogs. However, due to the small number of infected 
dogs resulting in a low statistical power these associations might have been 
missed. 
No hemoplasma-infected dogs in the present study exhibited clinical signs 
attributable to hemoplasmosis and PCV values of all infected dogs were found 
to be within or close to the reference range. This finding is in accordance with 
previous publications which suggested that co-factors, such as splenectomy or 
severe immunosuppression, are involved in the pathogenesis of canine 
hemoplasmosis (2, 3, 7, 14, 19, 20, 33). In view of the limited pathogenic 
potential in immunocompetent hosts and the low hemoplasma prevalence 
reported in this study, routine screening of blood donors for canine 
hemoplasmas seems not of utmost importance in dogs in Switzerland. The six 
blood donors that had been included in the present study tested all negative 
for canine hemoplasmas. Nonetheless, the investigation of blood donors by 
sensitive PCR-based methods should be considered in countries with high 
infection rates or if the recipient dog is splenectomized or severely 
immunocompromised. 
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It has been suspected that hemoplasma-infected dogs remain chronic carriers 
(3, 20). So far, the confirmation of this assumption was hampered by the low 
sensitivity of microscopy-based diagnostics. In one case a chronic carrier 
status was confirmed in a experimentally infected dog by the occurrence of 
organisms in blood smears upon splenectomy one year after inoculation (3). 
By means of sensitive real-time PCR-based diagnostics, we now followed 
chronic carrier dogs for three to 13 months: all follow-up samples of a 
‘Candidatus M. haematoparvum’ and two M. haemocanis infected dogs tested 
PCR positive. 
The hemoplasma blood loads in the present study were rather low and could 
not be exactly determined in two hemoplasma PCR-positive dogs, although 
the two applied PCR assays were shown to be highly sensitive (30). More 
PCR reactions would have been necessary to accurately quantify the blood 
loads in these two dogs. It may be speculated that other dogs might have had 
similarly low hemoplasma loads and that thus some hemoplasma-infected 
dogs were not detected in the present study. However, we assume that 
hemoplasma infections with blood loads close to the detection limit are not of 
great clinical relevance. 
In summary, canine hemoplasma infections were rarely detected in dogs in 
Switzerland. Phylogenetic analysis of the 16S rRNA gene revealed a high 
identity (>99%) of M. haemocanis and ‘Candidatus M. haematoparvum’ 
isolates from dogs in Switzerland to previously published sequences from 
dogs in other countries. The use of sensitive PCR-based methods represent 
an essential prerequisite to investigate in more depth the pathogenesis and 
possible transmission routes of canine hemoplasmas and the role of chronic 
carrier dogs in the epizoology of these agents. 
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6 Figures and Tables 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1. Follow-up of hemoplasma infected dogs. 
 
Course of ‘Candidatus M. haematoparvum’ (A) and M. haemocanis (B-C), 
infections. The loads are presented as log DNA copy number per ml of blood 
(left y-axis); the PCV is given in % (right y-axis). A) dog 252, B) dog 1725 and 
C) dog 201. The arrow (A) indicates the end of antineoplastic chemotherapy 
with lomustine in dog 252. The period of prednisolone administration in 
dog 201 (C) is indicated by a gray area. † dog was subsequently euthanized 
for reasons unrelated to canine hemoplasmosis. 
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FIGURE 2. Phylogenetic tree. 
 
Phylogenetic tree demonstrating the relationship of the Swiss canine 
hemoplasma isolates to other hemoplasma species using the neighbor joining 
method. Mycoplasma suis (AF029394), ‘Candidatus Mycoplasma 
haemolamae’ (AF306346), ‘Candidatus Mycoplasma haemodidelphidis’ 
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(AF178676), Mycoplasma ovis (AF338268), Mycoplasma wenyonii 
(DQ641256), ‘Candidatus Mycoplasma kahanei’ (AF338269), ‘Candidatus 
M. haemominutum’ (DQ157148), ‘Candidatus M. haematoparvum’ (dog 252, 
Switzerland, EF416569; France, AY532390; USA, AY383241), Mycoplasma 
coccoides (AY171918), ‘Candidatus Mycoplasma turicensis’ (DQ157150), 
Mycoplasma haemomuris (U82963), ‘Candidatus Mycoplasma haemobovis’ 
(Switzerland, M.L. Meli, in preparation), M. haemofelis (DQ157157) and 
M. haemocanis (dog 201, Switzerland, EF416566; dog 1725, Switzerland, 
EF416568; dog 1769, Switzerland, EF416567; USA, AF407208; Japan, 
AY529641; Germany, AY150973) are shown. Mycoplasma pneumoniae 
(U00089) was used as an out-group. The numbers at the nodes were 
generated from 1,000 bootstrap resamplings; values of <700 are not shown. 
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TABLE 1. Dog identity, breed, gender, age, PCV, clinical diagnosis and 
recorded travel history of M. haemocanis PCR-positive dogs. 
No.1 
 
Breed 
 
Gender2 Age 
(years) 
PCV3 
(%) 
Clinical 
diagnosis 
Travel history 
(countries 
visited) 
Travel history 
(to canton 
Ticino) 
201 Greyhound† 
 
fn 
 
9 
 
62 
 
Protein loosing 
enteropathy 
Spain 
 
No 
 
551 Bloodhound 
 
fn 
 
7 
 
55 
 
Lipoma 
 
No 
 
Yes 
 
677 Lagotto 
Romagnolo† 
mc 
 
10 
 
45 
 
Brain tumor 
 
Italy 
 
No 
 
954 Alaskan 
Malamute† 
fn 
 
6 
 
40 
 
Myositis 
 
Germany4 
 
Unknown4 
 
1619 Rottweiler 
 
fn 
 
7 
 
45 
 
Mast cell 
tumor, benign 
spleen nodule 
France 
 
Yes 
 
1725 Rottweiler† 
 
m 
 
5 
 
42 
 
Bite wound 
 
Serbia 
 
No 
1769 Dachshund m 
 
13 
 
47 
 
Mitral valve 
endocardiosis 
Serbia, Austria No 
 
1857 Crossbreed m 6 54 Degloving limb 
injury 
Italy Yes 
 
 
1 No. = Dog identity number; 2 m = male, f = female, c = castrated, n = neutered; 3 Reference range: 
42 - 55% (5 to 95% quantile); 4 data incomplete because dog 954 was adopted at the age of 4 years; 
† dogs were euthanized or died subsequently for reasons unrelated to canine hemoplasmosis. 
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TABLE 2. Dog identity, breed, gender, age, PCV, clinical diagnosis and 
recorded travel history of ‘Candidatus M. haematoparvum’ PCR-positive dogs. 
No.1  Breed Gender2 Age 
(years)
PCV3
(%) 
Clinical 
diagnosis 
Travel 
history 
(countries 
visited) 
Travel 
history 
(to canton 
Ticino) 
252 Crossbreed 
 
mc 
 
12 
 
43 
 
Mast cell tumor Mexico, USA, 
Italy 
No 
 
519 Maltese 
 
f 
 
3 
 
49 
 
Bite wound 
 
Italy  
 
No 
 
1756 Crossbreed fn 10 47 Gastroenteritis Spain No 
 
 
1 No. = Dog identity number; 2 m = male, f = female, c = castrated, n = neutered; 3 Reference range: 
42 - 55% (5 to 95% quantile). 
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